Phreesia, Inc. (NYSE:PHR – Get Free Report) insider Yvonne Hui sold 744 shares of Phreesia stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $23.25, for a total value of $17,298.00. Following the transaction, the insider now owns 30,019 shares of the company’s stock, valued at approximately $697,941.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.
Yvonne Hui also recently made the following trade(s):
- On Tuesday, July 16th, Yvonne Hui sold 283 shares of Phreesia stock. The shares were sold at an average price of $23.74, for a total value of $6,718.42.
Phreesia Stock Performance
Phreesia stock opened at $23.76 on Friday. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.03. The stock has a fifty day moving average of $23.63 and a 200 day moving average of $22.75. Phreesia, Inc. has a one year low of $12.05 and a one year high of $29.16.
Institutional Investors Weigh In On Phreesia
Wall Street Analyst Weigh In
Several analysts recently commented on the stock. JMP Securities reissued a “market outperform” rating and set a $30.00 price objective on shares of Phreesia in a research report on Thursday, September 5th. Truist Financial increased their price target on shares of Phreesia from $29.00 to $31.00 and gave the company a “buy” rating in a report on Friday, September 6th. KeyCorp decreased their price objective on shares of Phreesia from $27.00 to $25.00 and set an “overweight” rating for the company in a report on Thursday, July 11th. Needham & Company LLC reiterated a “buy” rating and set a $29.00 target price on shares of Phreesia in a research note on Thursday, September 5th. Finally, DA Davidson restated a “buy” rating and issued a $32.00 price target on shares of Phreesia in a research note on Thursday, September 5th. One investment analyst has rated the stock with a hold rating and eleven have given a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $29.42.
Read Our Latest Stock Analysis on Phreesia
About Phreesia
Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.
Further Reading
- Five stocks we like better than Phreesia
- How to buy stock: A step-by-step guide for beginners
- 3 Fresh Stock Buybacks: These are the Ones to Buy
- The Risks of Owning Bonds
- Tesla’s New Buy Rating: Why Analysts Are Optimistic
- Buy P&G Now, Before It Sets A New All-Time High
- Is Halliburton Stock a Good Buy at Current Levels?
Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.